AORT insider files Form 144 for 7,992-share sale on NYSE
Rhea-AI Filing Summary
Artivion filed a Form 144 reporting a proposed sale of 7,992 shares of common stock through Morgan Stanley Smith Barney LLC on the NYSE with an aggregate market value of $307,612.08. The filing lists total shares outstanding as 47,183,658 and shows the securities were acquired on 08/08/2025 via a stock option exercise with payment made in cash.
The filer reports “Nothing to Report” for sales in the past three months and includes the standard representation that the seller is not aware of undisclosed material adverse information. The notice is a formal Rule 144 disclosure of a planned insider sale.
Positive
- None.
Negative
- None.
Insights
TL;DR: Insider exercised options and filed a Form 144 to sell 7,992 shares; filing discloses cash payment and broker details.
The Form 144 documents an insider sale tied to a stock option exercise executed and paid in cash on 08/08/2025. The sale is to be routed through Morgan Stanley Smith Barney LLC on the NYSE and the filing reports aggregate market value of $307,612.08. The filer reports no other sales in the prior three months. From a financial perspective, this is a standard disclosure of an insider liquidity event; the filing provides transparency on timing, quantity, and payment method.
TL;DR: Routine Rule 144 notice reflecting an option exercise and planned sale; includes seller certification about undisclosed material information.
The document is a formal Rule 144 notice showing the insider exercised options and intends to sell the resulting 7,992 shares. The filing includes the required certification that the seller is not aware of material adverse information and references Rule 10b5-1 plan adoption language without providing a plan date. It is a governance-compliant disclosure of an insider transaction; no regulatory exceptions or qualifications are disclosed within the form.